ASRT logo

Assertio Holdings (ASRT) Company Overview

Profile

Full Name:

Assertio Holdings, Inc.

Sector:

Healthcare

Country:

United States

IPO:

December 3, 1997

Indexes:

Not included

Description:

Assertio Holdings (ASRT) is a pharmaceutical company focused on developing and commercializing innovative medicines. They specialize in pain management and neurology, offering products that improve patients' quality of life. ASRT aims to provide effective treatments while ensuring safety and accessibility for healthcare providers and patients.

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Nov 11, 2024

Recent annual earnings:

Mar 11, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 18, 2021

Analyst ratings

Recent major analysts updates

Dec 16, 24 HC Wainwright & Co.
Buy
Nov 25, 24 HC Wainwright & Co.
Buy
Jul 26, 24 Maxim Group
Buy
Jul 3, 24 HC Wainwright & Co.
Buy
May 28, 24 Alliance Global Partners
Buy
Mar 12, 24 Lake Street
Buy
Nov 3, 23 BWS Financial
Buy
Aug 4, 23 BWS Financial
Buy
May 10, 23 Lake Street
Buy
May 10, 23 BWS Financial
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Assertio Holdings?
  • Does Assertio Holdings pay dividends?
  • What sector is Assertio Holdings in?
  • What industry is Assertio Holdings in?
  • What country is Assertio Holdings based in?
  • When did Assertio Holdings go public?
  • Is Assertio Holdings in the S&P 500?
  • Is Assertio Holdings in the NASDAQ 100?
  • Is Assertio Holdings in the Dow Jones?
  • When was Assertio Holdings's last earnings report?
  • When does Assertio Holdings report earnings?
  • Should I buy Assertio Holdings stock now?

What is the ticker symbol for Assertio Holdings?

The ticker symbol for Assertio Holdings is NASDAQ:ASRT

Does Assertio Holdings pay dividends?

No, Assertio Holdings does not pay dividends

What sector is Assertio Holdings in?

Assertio Holdings is in the Healthcare sector

What industry is Assertio Holdings in?

Assertio Holdings is in the Drug Manufacturers - Specialty & Generic industry

What country is Assertio Holdings based in?

Assertio Holdings is headquartered in United States

When did Assertio Holdings go public?

Assertio Holdings's initial public offering (IPO) was on December 3, 1997

Is Assertio Holdings in the S&P 500?

No, Assertio Holdings is not included in the S&P 500 index

Is Assertio Holdings in the NASDAQ 100?

No, Assertio Holdings is not included in the NASDAQ 100 index

Is Assertio Holdings in the Dow Jones?

No, Assertio Holdings is not included in the Dow Jones index

When was Assertio Holdings's last earnings report?

Assertio Holdings's most recent earnings report was on Nov 11, 2024

When does Assertio Holdings report earnings?

The next expected earnings date for Assertio Holdings is Mar 11, 2025

Should I buy Assertio Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions